Published in Carcinogenesis on February 01, 1987
Cell proliferation and renal carcinogenesis. Environ Health Perspect (1993) 0.90
Compensatory regeneration, mitogen-induced liver growth, and multistage chemical carcinogenesis. Environ Health Perspect (1993) 0.87
Sequential dietary exposure to aflatoxin B1 and fumonisin B1 in F344 rats increases liver preneoplastic changes indicative of a synergistic interaction. Food Chem Toxicol (2016) 0.75
Long-term, near-total liver replacement by transplantation of isolated hepatocytes in rats treated with retrorsine. Am J Pathol (1998) 2.62
Diminished response to cytotoxic therapy in G-6-PD deficiency. Lancet (1980) 1.39
Neural correlates of cognitive control of reaching movements in the dorsal premotor cortex of rhesus monkeys. J Neurophysiol (2011) 1.29
Liver regeneration in response to partial hepatectomy in rats treated with retrorsine: a kinetic study. J Hepatol (1999) 1.28
Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27
Hepatic cholesterol in lead nitrate induced liver hyperplasia. Chem Biol Interact (1984) 1.26
Cholesterol content in tumor tissues is inversely associated with high-density lipoprotein cholesterol in serum in patients with gastrointestinal cancer. Cancer (1994) 1.20
Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19
Massive liver replacement by transplanted hepatocytes in the absence of exogenous growth stimuli in rats treated with retrorsine. Am J Pathol (2001) 1.17
Requirement of cell proliferation for the initiation of liver carcinogenesis as assayed by three different procedures. Cancer Res (1981) 1.15
Search for a supersymmetric partner to the top quark in final states with jets and missing transverse momentum at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.13
Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK1 dysregulation is an early event maintained along tumor progression. Oncogene (2012) 1.11
A growth-constrained environment drives tumor progression invivo. Proc Natl Acad Sci U S A (2001) 1.11
Occurrence of cell death (apoptosis) during the involution of liver hyperplasia. Lab Invest (1985) 1.09
Occurrence of cell death (apoptosis) in preneoplastic and neoplastic liver cells. A sequential study. Am J Pathol (1984) 1.09
Induction of two different modes of cell death, apoptosis and necrosis, in rat liver after a single dose of thioacetamide. Am J Pathol (1991) 1.09
Increased ROS generation and p53 activation in alpha-lipoic acid-induced apoptosis of hepatoma cells. Apoptosis (2007) 1.08
Choline-deficiency fatty liver: impaired release of hepatic triglycerides. J Lipid Res (1968) 1.08
Rapid induction of apoptosis in rat liver by cycloheximide. Am J Pathol (1992) 1.07
Cholesterol metabolism during the growth of a rat ascites hepatoma (Yoshida AH-130). Br J Cancer (1992) 1.06
In vivo hepatocyte proliferation is inducible through a TNF and IL-6-independent pathway. Oncogene (1998) 1.02
Cyclin D1 is an early target in hepatocyte proliferation induced by thyroid hormone (T3). FASEB J (2001) 1.00
Induction of pancreatic acinar cell proliferation by thyroid hormone. J Endocrinol (2005) 1.00
Cell deletion by apoptosis during regression of renal hyperplasia. Am J Pathol (1989) 0.98
Transplantation of normal hepatocytes modulates the development of chronic liver lesions induced by a pyrrolizidine alkaloid, lasiocarpine. Carcinogenesis (1995) 0.97
Prevalence and phenotype of subjects carrying rare variants in the Italian registry for alpha1-antitrypsin deficiency. J Med Genet (2005) 0.97
Hepatic glucose-6-phosphate dehydrogenase, cholesterogenesis, and serum lipoproteins in liver regeneration after partial hepatectomy. Exp Mol Pathol (1986) 0.97
Cell proliferation and promotion of rat liver carcinogenesis: different effect of hepatic regeneration and mitogen induced hyperplasia on the development of enzyme-altered foci. Carcinogenesis (1990) 0.96
Inability of mitogen-induced liver hyperplasia to support the induction of enzyme-altered islands induced by liver carcinogens. Cancer Res (1987) 0.96
Increased expression of c-fos, c-jun and LRF-1 is not required for in vivo priming of hepatocytes by the mitogen TCPOBOP. Oncogene (1997) 0.95
An electron microscopic study of apoptosis induced by cycloheximide in rat liver. Liver (1994) 0.93
Early increase in cyclin-D1 expression and accelerated entry of mouse hepatocytes into S phase after administration of the mitogen 1, 4-Bis[2-(3,5-Dichloropyridyloxy)] benzene. Am J Pathol (2000) 0.93
Cell proliferation induced by triiodothyronine in rat liver is associated with nodule regression and reduction of hepatocellular carcinomas. Cancer Res (2000) 0.93
Apoptosis: a general comment. FASEB J (1991) 0.91
Differences in the steady-state levels of c-fos, c-jun and c-myc messenger RNA during mitogen-induced liver growth and compensatory regeneration. Hepatology (1993) 0.91
Total and HDL cholesterol in human hematologic neoplasms. Int J Hematol (1991) 0.90
Triiodothyronine stimulates hepatocyte proliferation in two models of impaired liver regeneration. Cell Prolif (2008) 0.89
Liver cell proliferation induced by a single dose of lead nitrate. Am J Pathol (1983) 0.89
Sexually differentiated response to choline in choline deficiency and ethionine intoxication. Int J Exp Pathol (1995) 0.88
Effects of cell proliferation and cell death (apoptosis and necrosis) on the early stages of rat hepatocarcinogenesis. Carcinogenesis (1996) 0.88
Mitogenesis by ligands of nuclear receptors: an attractive model for the study of the molecular mechanisms implicated in liver growth. Cell Death Differ (2003) 0.87
Liver hyperplasia is not necessarily associated with increased expression of c-fos and c-myc mRNA. Carcinogenesis (1990) 0.87
Gap junctional intercellular communication and cell proliferation during rat liver carcinogenesis. Environ Health Perspect (1993) 0.87
Variations of serum lipoproteins during cell proliferation induced by lead nitrate. Exp Mol Pathol (1989) 0.87
Compensatory regeneration, mitogen-induced liver growth, and multistage chemical carcinogenesis. Environ Health Perspect (1993) 0.87
Induction of hepatocyte proliferation by retinoic acid. Carcinogenesis (2004) 0.87
Dietary orotic acid, a new selective growth stimulus for carcinogen altered hepatocytes in rat. Cancer Lett (1982) 0.86
Role of cholesterol synthesis and esterification in the growth of CEM and MOLT4 lymphoblastic cells. Biochem J (1997) 0.86
Choline enhances acetylaminofluorene promotion of liver carcinogenesis in female but not in male rats. Carcinogenesis (1992) 0.86
Serum lipoprotein pattern as modified in G6PD-deficient children during haemolytic anaemia induced by fava bean ingestion. Int J Exp Pathol (1992) 0.86
Acinar cell carcinoma of rat pancreas: regulation of cholesterol esterification. Br J Cancer (1986) 0.86
Further evidence that mitogen-induced cell proliferation does not support the formation of enzyme-altered islands in rat liver by carcinogens. Carcinogenesis (1989) 0.84
Sexual dimorphism in the regulation of cell turnover during liver hyperplasia. Chem Biol Interact (1995) 0.83
Cell proliferation in rat kidney induced by 1,2-dibromoethane. Toxicol Lett (1987) 0.83
Cholesterol and phospholipid composition of mitochondria and microsomes isolated from morris hepatoma 5123 and rat liver. FEBS Lett (1973) 0.83
Uneven copper distribution in the human newborn liver. Hepatology (1987) 0.83
Ploidy and nuclearity of rat hepatocytes after compensatory regeneration or mitogen-induced liver growth. Carcinogenesis (1993) 0.83
Labelling of liver and plasma lecithins after injection of 1-2-14C-2-demethylaminoethanol and 14C-L-methionine-methyl to choline deficient rats. Lipids (1969) 0.83
Induction of cellular DNA synthesis in the pancreas and kidneys of rats by peroxisome proliferators, 9-cis retinoic acid, and 3,3',5-triiodo-L-thyronine. Cancer Res (1997) 0.82
Roles of growth factors and of tumor necrosis factor-alpha on liver cell proliferation induced in rats by lead nitrate. Lab Invest (1994) 0.82
On the variability of MboI repeated sequences and 5S rDNA in Muraena helena and Gymnothorax unicolor (Anguilliformes, Muraenidae). Chromosome Res (2000) 0.82
Transient inhibition by orotic acid does not abolish the in vivo response of rat hepatocytes to a direct mitogen, lead nitrate. J Hepatol (1997) 0.82
9-cis retinoic acid is a direct hepatocyte mitogen in rats. Life Sci (1996) 0.81
Regulatory effects of senescence marker protein 30 on the proliferation of hepatocytes. Pathol Int (2001) 0.81
Effect of fasting/refeeding on the incidence of chemically induced hepatocellular carcinoma in the rat. Carcinogenesis (1999) 0.81
The resistance phenotype in the development and treatment of cancer. Lancet Oncol (2000) 0.81
Different effects of regenerative and direct mitogenic stimuli on the growth of initiated cells in the resistant hepatocyte model. Jpn J Cancer Res (1993) 0.81
Measurement of Z boson production in Pb-Pb collisions at sqrt[s(NN)]=2.76 TeV with the ATLAS detector. Phys Rev Lett (2013) 0.81
Possible roles of nonparenchymal cells in hepatocyte proliferation induced by lead nitrate and by tumor necrosis factor alpha. Hepatology (1996) 0.81